"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Descriptor ID |
D010300
|
MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 4 | 0 | 4 |
1996 | 2 | 0 | 2 |
1997 | 6 | 2 | 8 |
1998 | 6 | 1 | 7 |
1999 | 13 | 1 | 14 |
2000 | 10 | 2 | 12 |
2001 | 16 | 0 | 16 |
2002 | 12 | 1 | 13 |
2003 | 12 | 2 | 14 |
2004 | 12 | 2 | 14 |
2005 | 18 | 4 | 22 |
2006 | 18 | 2 | 20 |
2007 | 21 | 1 | 22 |
2008 | 19 | 5 | 24 |
2009 | 21 | 4 | 25 |
2010 | 24 | 1 | 25 |
2011 | 21 | 2 | 23 |
2012 | 18 | 1 | 19 |
2013 | 15 | 1 | 16 |
2014 | 24 | 2 | 26 |
2015 | 16 | 6 | 22 |
2016 | 12 | 4 | 16 |
2017 | 17 | 1 | 18 |
2018 | 18 | 1 | 19 |
2019 | 18 | 1 | 19 |
2020 | 12 | 0 | 12 |
2021 | 22 | 2 | 24 |
2022 | 15 | 0 | 15 |
2023 | 21 | 0 | 21 |
2024 | 17 | 2 | 19 |
2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2025 Mar; 132:107309.
-
Response to the letter "Reassessing the hypothesis of essential tremor as a prodromal feature of Parkinson's disease". Parkinsonism Relat Disord. 2025 Mar; 132:107280.
-
Use of Robust Norming to Create a Sensitive Cognitive Summary Score in De Novo Parkinson's Disease: An Illustrative Example. Mov Disord. 2025 Mar; 40(3):468-477.
-
A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline data. Parkinsonism Relat Disord. 2025 Mar; 132:107257.
-
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson's disease risk. Nat Aging. 2025 Feb; 5(2):205-218.
-
Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024 Dec; 23(12):1503-1513.
-
Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial. Nat Med. 2024 Dec; 30(12):3669-3675.
-
Olfactory deficit and gastrointestinal dysfunction precede motor abnormalities in alpha-Synuclein G51D knock-in mice. Proc Natl Acad Sci U S A. 2024 Sep 24; 121(39):e2406479121.
-
Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta-Analysis. Mov Disord Clin Pract. 2024 Oct; 11(10):1195-1202.
-
Effects of Statistical Practices for Longitudinal Group Comparison of the Penetration-Aspiration Scale on Power and Effect Size Estimation: A Monte Carlo Simulation Study. Dysphagia. 2025 Apr; 40(2):388-398.